(Q35692953)

9 August 2017

1 reference

title

Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography (English)

1 reference

9 August 2017

0 references

0 references

William E Klunk

1

0 references

Agneta Nordberg

object named as

Agneta Nordberg

3

0 references

Bradley Hyman

8

object named as

Bradley T Hyman

1 reference

9 August 2017

9

Bengt Långström

1 reference

9 August 2017

Henry Engler

2

1 reference

9 August 2017

Brian J Bacskai

4

1 reference

9 August 2017

Yanming Wang

5

1 reference

9 August 2017

Julie C Price

6

1 reference

9 August 2017

Mats Bergström

7

1 reference

9 August 2017

Chester A Mathis

10

1 reference

9 August 2017

1 November 2003

1 reference

Neuroimaging clinics of North America

9 August 2017

1 reference

9 August 2017

13

1 reference

9 August 2017

781-9, ix

1 reference

9 August 2017

4

1 reference

Education and the prevalence of dementia and Alzheimer's disease

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

The Alzheimer diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

The cytoskeleton in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

How important is oxidative damage? Lessons from Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Magnetic resonance spectroscopic changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Commentary and perspective on studies of beta amyloid neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Tau mutations cause frontotemporal dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Diagnostic criteria for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Biochemical assay for amyloid beta deposits to distinguish Alzheimer's disease from other dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Biological markers of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Purification and cloning of amyloid precursor protein beta-secretase from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Imaging Alzheimer's amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Development of an anti-A beta monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Neuroimaging of vessel amyloid in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900092-3

7 January 2021

10.1016/S1052-5149(03)00092-3

Identifiers

DOI

1 reference

release_cfzphizuinbx5d7zzy5e4zlbyy

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cfzphizuinbx5d7zzy5e4zlbyy

24 November 2022

mapped directly with Wikidata item

1 reference